Intersouth Partners
Intersouth Partners is an early-stage venture capital firm that invests in technology and life science companies.
Business Model:
Revenue: $10M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Intersouth Partners Information
Geographic Data
Address: 102 City Hall Plz
City: Durham
State: NC
Zip: 27701
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Intersouth Partners is an early-stage venture capital firm that invests in technology and life science companies.
Contact Phone:
+19194936640
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 3/2003 | Aldagen | Series B | 4.9M |
| 7/2000 | Alerts.com, Inc. | Series B | 14M |
| 9/2007 | Proteon Therapeutics | Series A | 12M |
| 7/2008 | Athenix | Series D | 10M |
| 9/2010 | CallMiner | Series C | 0 |
| 5/2010 | Arsenal Medical | Venture Round | 10M |
| 8/2011 | Proteon Therapeutics | Series C | 15.2M |
| 3/2016 | 6fusion | Venture Round | 0 |
| 10/2000 | StemCo Biomedical | Series A | 4M |
| 10/2011 | 480 Biomedical | Series A | 15M |
| 2/2010 | PeopleMatter | Venture Round | 7.2M |
| 11/2011 | simplifyMD | Series A | 4.5M |
| 10/2010 | Adaptivity | Series A | 7.2M |
| 4/2013 | Advanced Animal Diagnostics | Series B | 6M |
| 8/2005 | Ziptronix | Series C | 7.2M |
| 7/2004 | Alimera Sciences | Series A | 26.8M |
| 5/2003 | Ziptronix | Series B | 17.4M |
| 9/2018 | Lyra Therapeutics | Series B | 0 |
| 10/2015 | LocationSmart | Venture Round | 0 |
| 2/2019 | CSA Medical | Venture Round | 45.2M |
| 12/2013 | CSA Medical | Series C | 16M |
| 4/2010 | Overture Networks | Venture Round | 0 |
| 3/2012 | Adaptivity | Series B | 3M |
| 9/2015 | CallMiner | Venture Round | 0 |
| 6/2013 | Locaid | Series D | 0 |
| 6/1996 | Accipiter | Seed Round | 500k |
| 10/2008 | Biolex Therapeutics | Series D | 0 |
| 1/2012 | Semprius | Venture Round | 7.5M |
| 7/2009 | Viamet Pharmaceuticals | Series B | 25M |
| 10/2014 | Viamet Pharma | Series D | 60M |
| 12/2009 | PeopleMatter | Series A | 7M |
| 1/2007 | Clarabridge | Series B | 7.2M |
| 3/2003 | StemCo Biomedical | Series B | 0 |
| 11/2013 | Argos Therapeutics | Series E | 0 |
| 4/2012 | Argos Therapeutics | Series D | 0 |
| 3/2001 | Encelle | Venture Round | 4M |
| 8/2003 | Biolex Therapeutics | Venture Round | 0 |
| 8/2002 | Trinity Convergence | Series B | 4.5M |
| 4/2004 | TapRoot Systems | Series A | 7M |
| 11/2013 | ZOEN | Debt Financing | 103k |
| 9/2002 | Infoglide Software Corporation | Series E | 0 |
| 7/2016 | Azalea Health | Series B | 10.5M |
| 9/2011 | Arsenal Medical | Debt Financing | 3M |
| 3/2003 | COVEGA | Series A | 17M |
| 2/2004 | Integrien | Series A | 5.5M |
| 3/1999 | Sentillion | Series A | 2.7M |
| 11/2009 | Zenph Sound Innovations | Series A | 10.7M |
| 6/2012 | Locaid | Private Equity Round | 5.8M |
| 8/2003 | Invistics | Series A | 2.5M |
| 8/2010 | 6fusion | Series A | 3M |
| 1/2005 | Invistics | Series B | 5M |
| 11/2009 | Calibra Medical | Venture Round | 1.4M |
| 6/2003 | XActional | Venture Round | 0 |
| 6/2007 | Argolyn Bioscience | Series A | 15.8M |
| 11/1997 | Accipiter | Series A | 3M |
| 10/2000 | NetOctave | Series A | 15.6M |
| 6/2015 | Arsenal Medical | Venture Round | 0 |
| 8/2006 | COVEGA | Venture Round | 10M |
| 6/2012 | Esanex | Venture Round | 15M |
| 8/2022 | EDJX | Venture Round | 12M |
| 4/2008 | Aldagen | Series D | 18.4M |
| 2/2002 | Norak Biosciences | Series B | 0 |
| 6/2009 | Semprius | Series B | 0 |
| 12/2011 | CSA Medical | Series B | 20.5M |
| 1/2006 | Athenix | Series C | 13M |
| 9/2007 | Aldagen | Series C | 9M |
| 8/2004 | Jaggaer (SciQuest) | Venture Round | - |
| 3/2003 | Sopherion Therapeutics | Series A | 0 |
| 3/2004 | MaxCyte | Series B | 10.7M |
| 6/2006 | Nitronex | Venture Round | 21.8M |
| 7/2007 | Cempra | Series B | 0 |
| 1/2004 | Athenix | Series B | 12.5M |
| 8/2005 | Ablatrics, Inc | Venture Round | 5.5M |
| 6/2008 | siXis | Series A | 5M |
| 3/2007 | Defywire | Venture Round | 0 |
| 3/2006 | FlatBurger | Seed Round | 0 |
| 10/2013 | PeopleMatter | Series E | 16M |
| 2/2005 | CallMiner | Venture Round | - |
| 4/2009 | Bright View Technologies | Series C | 0 |
| 3/2006 | Proteon Therapeutics | Series A | 19M |
| 6/2007 | Serenex | Series D | 0 |
| 10/2005 | Serenex | Series C | 30M |
| 1/2008 | Zenoss | Series B | 11M |
| 9/2002 | Serenex | Series B | 15M |
| 10/2002 | Overture Networks | Series B | 0 |
| 4/2005 | Defywire | Series B | 0 |
| 2/2002 | NetOctave | Series B | 7.8M |
| 8/2013 | Argos Therapeutics | Series E | 0 |
| 6/2007 | Viamet Pharmaceuticals | Series A | 4M |
| 8/2008 | Calibra Medical | Series B | 35M |
| 8/2005 | Viamet Pharmaceuticals | Series A | 200k |
| 11/2005 | Locaid | Series A | 5M |
| 1/2007 | Ziptronix | Series D | 2.8M |
| 6/2003 | Defywire | Series A | 4.5M |
| 8/2008 | Clarabridge | Series C | 12M |
| 2/2008 | Ziptronix | Venture Round | 2.8M |
| 12/2006 | Aldagen | Series C | 0 |
| 1/2009 | Ziptronix | Venture Round | 1.8M |
| 2/2002 | Aldagen | Series A | 6M |
| 10/2012 | Zenoss | Series C | 25M |
| 8/2006 | Zenoss | Series A | 4.8M |
| 12/2003 | KAI Pharmaceuticals | Series A | 17M |
| 5/2006 | KAI Pharmaceuticals | Series B | 35M |
| 9/2007 | Overture Networks | Series C | 12.3M |
| 2/2011 | Locaid | Series C | 13M |
| 1/2007 | 6th Sense Analytics | Series A | 5M |
| 9/2006 | nContact Surgical | Series B | 7.5M |
| 4/2012 | Advanced Animal Diagnostics | Series B | 4M |
| 11/2005 | HexaTech | Series A | 8.9M |
| 7/1999 | Alerts.com, Inc. | Series A | 2.5M |
| 9/2012 | ABT Molecular Imaging | Series C | 6M |
| 11/2007 | nContact Surgical | Series C | 8.5M |
| 6/2009 | Applied Genetics Technologies Corporation | Venture Round | 11.8M |
| 10/2010 | CallMiner | Venture Round | 0 |
| 11/2003 | Applied Genetics Technologies Corporation | Venture Round | 27M |
| 11/2012 | Applied Genetics Technologies Corporation | Series B | 0 |
| 1/2020 | Lyra Therapeutics | Series C | 0 |
| 6/2009 | Cempra | Series C | 46M |
| 7/2006 | CallMiner | Series B | 0 |
| 9/2001 | Sentillion | Series C | 0 |
| 7/2002 | Zoom Culture | Series C | 2.5M |
| 4/2006 | Cempra | Series A | 22M |
| 10/2006 | Jacket Micro Devices | Venture Round | 12M |
| 3/2015 | Vascular Pharmaceuticals | Series A | 9M |
| 1/2010 | MicroCHIPS | Venture Round | 16.5M |
| 5/2021 | Advanced Animal Diagnostics | Series E | 0 |
| 7/2007 | Semprius | Series A | 4.1M |
| 6/2011 | Semprius | Series C | 20M |
| 10/2009 | Alimera Sciences | Series C | 5M |
| 4/2000 | Sentillion | Series B | 8.8M |
| 4/2005 | Integrian | Series B | 13M |
| 9/2001 | Athenix | Series A | 8M |
| 5/2011 | PeopleMatter | Series B | 7.2M |
| 9/2005 | Biolex Therapeutics | Series B | 36M |
| 5/2007 | Biolex Therapeutics | Series C | 30M |
| 4/2005 | Digital Safety Technologies | Venture Round | 41.1M |
| 6/2015 | 480 Biomedical | Series C | 0 |
| 9/2007 | Arsenal Medical | Series B | 13.1M |
| 9/2011 | Adaptivity | Venture Round | 6M |
| 2/2000 | Accordant Health Services | Venture Round | 14M |
| 5/2009 | Proteon Therapeutics | Series B | 50M |
| 9/2012 | Vascular Pharmaceuticals | Series A | 16M |
| 7/2004 | Serenex | Venture Round | 8M |
| 11/2005 | Alimera Sciences | Series B | 31.8M |
| 3/2013 | PeopleMatter | Series D | 19M |
| 3/2008 | Alimera Sciences | Series C | 30M |
| 5/2014 | Proteon Therapeutics | Series D | 0 |
| 3/2011 | Advanced Animal Diagnostics | Series B | 11M |
| 5/2007 | FlatBurger | Series A | 0 |
| 1/2010 | ABT Molecular Imaging | Series A | 9M |
| 9/2004 | Cellective Therapeutics | Series A | 27.5M |
| 5/2008 | Argos Therapeutics | Series C | 17.1M |
| 3/2002 | Trinity Convergence | Series A | 3.1M |
| 2/2008 | Mixx | Series B | 2M |
| 8/2011 | 6fusion | Series B | 7M |
| 5/2002 | Zoom Culture | Series B | 7.1M |
| 10/2009 | Asensus Surgical | Post-IPO Equity | 0 |
| 8/2004 | CallMiner | Series A | 2M |
| 1/2008 | NovaMin Technology | Series C | 0 |
| 7/2000 | Zoom Culture | Series A | 0 |
| 6/2007 | Mixx | Series A | 1.5M |
| 1/2015 | Azalea Health | Venture Round | 1.5M |
| 6/2006 | Overture Networks | Series C | 0 |
| 11/2005 | 6th Sense Analytics | Venture Round | 1.7M |
| 9/2005 | TapRoot Systems | Series B | 6.5M |
| 5/2021 | Advanced Animal Diagnostics | Series E | 0 |
| 1/2020 | Lyra Therapeutics | Series C | 0 |
| 2/2019 | CSA Medical | Venture Round | 0 |
| 9/2018 | Lyra Therapeutics | Series B | 0 |
| 7/2016 | Azalea Health | Series B | 0 |
| 3/2016 | 6fusion | Venture Round | 0 |
| 10/2015 | LocationSmart | Venture Round | 0 |
| 9/2015 | CallMiner | Venture Round | 0 |
| 6/2015 | Arsenal Medical | Venture Round | 0 |
| 6/2015 | 480 Biomedical | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
